TABLE 7.
ADME/T study of the identified best-binding compounds from C. gigantea and C. affinis against DHFR, KOR, and COX-2 macromolecules.
| Property | Model name (Unit) | C1/C4 | C2a | C2b | C3 | C5 | C6 |
|---|---|---|---|---|---|---|---|
| Absorption | Water solubility (log mol/L) | −3.386 | −6.499 | −6.531 | −6.044 | −3.975 | −3.114 |
| CaCo2 permeability (log Papp in 10–6 cm/s) | −0.045 | 1.227 | 1.226 | 0.362 | 0.91 | 0.389 | |
| Intestinal absorption (human) (% absorbed) | 88.746 | 94.062 | 93.733 | 90.234 | 94.821 | 84.522 | |
| Skin permeability (log Kp) | −2.741 | −2.814 | −2.811 | −2.814 | −2.744 | −2.735 | |
| P-glycoprotein substrate | Yes | No | No | No | Yes | Yes | |
| P-glycoprotein I inhibitor | No | Yes | Yes | Yes | No | No | |
| P-glycoprotein II inhibitor | Yes | Yes | Yes | Yes | Yes | No | |
| Distribution | VDss (human) (log L/kg) | −0.104 | 0.266 | 0.268 | −0.288 | 0.375 | 0.201 |
| Fraction unbound (human) (Fu) | 0.083 | 0 | 0 | 0.123 | 0.112 | 0.067 | |
| BBB permeability (log BB) | −0.788 | 0.674 | 0.667 | −0.911 | −0.234 | −1.192 | |
| CNS permeability (log PS) | −3.135 | −1.773 | −1.773 | −3.365 | −1.816 | −2.434 | |
| Metabolism | CYP2D6 substrate | No | No | No | No | No | No |
| CYP3A4 substrate | Yes | Yes | Yes | Yes | No | No | |
| CYP1A2 inhibitor | Yes | No | No | Yes | Yes | Yes | |
| CYP2C19 inhibitor | Yes | No | No | No | Yes | No | |
| CYP2C9 inhibitor | Yes | No | No | No | Yes | Yes | |
| CYP2D6 inhibitor | No | No | No | No | Yes | No | |
| CYP3A4 inhibitor | No | No | No | No | Yes | Yes | |
| Excretion | Total clearance (log mL/min/kg) | 0.569 | 0.119 | −0.044 | 2.04 | 0.076 | 0.458 |
| Renal OCT2 substrate | No | No | No | No | No | No | |
| Toxicity | AMES toxicity | No | No | No | No | No | No |
| Max. tolerated dose (human) (log mg/kg/day) | −0.048 | −0.571 | −0.56 | 0.193 | 0.286 | 0.82 | |
| hERG I inhibitor | No | No | No | No | No | No | |
| hERG II inhibitor | No | Yes | Yes | No | Yes | No | |
| Oral rat acute toxicity (LD50) (mol/kg) | 2.283 | 2.467 | 2.478 | 1.734 | 2.318 | 2.563 | |
| Oral rat chronic toxicity (LOAEL) (log mg/kg_bw/day) | 2.152 | 0.856 | 0.873 | 2.897 | 0.992 | 1.516 | |
| Hepatotoxicity | No | No | No | No | No | No | |
| Skin sensitization | No | No | No | Yes | No | No | |
| Tetrahymena pyriformis toxicity (log ug/L) | 0.371 | 0.384 | 0.383 | 0.617 | 0.434 | 0.323 | |
| Minnow toxicity (log mM) | 1.32 | −1.309 | −1.345 | −0.969 | −0.102 | 1.498 | |
| Drug-likeness | Bioavailability score (%) | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
| Lipinski’s Rule of Five | Yes; 0 violation | No; 2 violations: MW > 350, XLOGP3>3.5 | No; 2 violations: MW > 350, XLOGP3>3.5 | No; 3 violations: MW > 350, Rotors>7, XLOGP3>3.5 | No; 1 violation: XLOGP3>3.5 | Yes; 0 violation |